Evidence map›Paper›PMID 22225407›Full record

ArticleMedical mycology2012

The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system.

Maged Muhammed, Beth Burgwyn Fuchs, Michael P Wu, Julia Breger, Jeffrey J Coleman, Eleftherios Mylonakis

Open access · bronzeAbstract read
In one paragraph

Article in Medical mycology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Conserved and Distinct Elements of Phagocytosis in Human andInternational journal of molecular sciences · 2021
    Review
  5. In Vitro and In Vivo Effect of Peptides Derived from 14-3-3Journal of fungi (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Diversity, evolution and medical applications of insect antimicrobial peptides.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2016
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Maged MuhammedHarvard Medical School, Massachusetts General Hospital, Division of Infectious Diseases, Boston, MA, USA.
Beth Burgwyn Fuchs
Michael P Wu
Julia Breger
Jeffrey J Coleman
Eleftherios Mylonakis
Harvard University · USMassachusetts General Hospital · US

Funding

Technical Mother Machine CoreP01AI083214 · NIAID · SCHEPENS EYE RESEARCH INSTITUTE · PI Michael S Gilmore · 2009 to 2026
$39.4M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
A C.elegans high-throughput assay for the identification of new antifungal agentsR01AI075286 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MYLONAKIS, ELEFTHERIOS · 2008 to 2010
$1.3M
Genome-wide investigations in fungal pathogens utilizing an invertebrate model hoR21AI079569 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MYLONAKIS, ELEFTHERIOS · 2009 to 2010
$484k
NIAID NIH HHS AI075286NIAID NIH HHS AI079569NIAID NIH HHS P01 AI 083214NIAID NIH HHS P01 AI083214NIAID NIH HHS R01 AI075286NIAID NIH HHS R21 AI079569NIAID NIH HHS T32 AI007061
6 · The paper itself

Abstract

Fusariosis is an emerging infectious complication of immune deficiency, but models to study this infection are lacking. The use of the soil nematode Caenorhabditis elegans as a model host to study the pathogenesis of Fusarium spp. was investigated. We observed that Fusarium conidia consumed by C. elegans can cause a lethal infection and result in more than 90% killing of the host within 120 hours, and the nematode had a significantly longer survival when challenged with Fusarium proliferatum compared to other species. Interestingly, mycelium production appears to be a major contributor in nematode killing in this model system, and C. elegans mutant strains with the immune response genes, tir-1 (encoding a protein containing a TIR domain that functions upstream of PMK-1) and pmk-1 (the homolog of the mammalian p38 MAPK) lived significantly shorter when challenged with Fusarium compared to the wild type strain. Furthermore, we used the C. elegans model to assess the efficacy and toxicity of various compounds against Fusarium. We demonstrated that amphotericin B, voriconazole, mancozeb, and phenyl mercury acetate significantly prolonged the survival of Fusarium-infected C. elegans, although mancozeb was toxic at higher concentrations. In conclusion, we describe a new model system for the study of Fusarium pathogenesis and evolutionarily preserved host responses to this important fungal pathogen.

Indexed as

Disease Models, AnimalAnimalsAntifungal AgentsCaenorhabditis elegansCaenorhabditis elegans ProteinsFusariosisFusariumHost-Pathogen InteractionsHumansMitogen-Activated Protein KinasesMyceliumSignal TransductionAntifungal AgentsCaenorhabditis elegans ProteinsMitogen-Activated Protein Kinases

Identifiers

PMID22225407
PMCPMC3759989
OpenAlexW2170009107

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.